Lipopolysaccharide extends the lifespan of mouse primary-cultured microglia

Yoko S. Kaneko, Akira Nakashima, Keiji Mori, Toshiharu Nagatsu, Ikuko Nagatsu, Akira Ota

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Microglial activation has been implicated in the recognition and phagocytic removal of degenerating neurons; however, this process must be tightly regulated in the central nervous system, because prolonged activation could damage normal neurons. We report that mouse primary-cultured microglia, which are destined to die within a few days under ordinary culture conditions, can live for more than 1 month when kept activated by lipopolysaccharide (LPS) treatment. Primary-cultured microglia treated with sublethal doses of LPS remained viable, without any measurable increase in apoptotic or necrotic cell death. LPS-treated microglia had an arborescent shape, with enlarged somata and thickened cell bodies. Although the amount of intracellular ATP in these microglia was reduced by 2 h after the start of LPS treatment, this had no effect on the viability of the cells. LPS treatment of microglia increased the antiapoptotic factor Bcl-xL protein level at day 1, although the level of the proapoptotic Bcl-associated X-protein was unaffected. Furthermore, the level of microtubule-associated light chain 3, a marker protein for autophagy, decreased at 3 h after exposure to LPS. These data show that the optimal dose of LPS suppresses the induction of both apoptosis and autophagy in primary-cultured microglia, allowing the cells to stay alive for more than 1 month. Because long-lived microglia may play critical roles in the exacerbation of neurodegeneration, our findings suggest that inducing a resting stage in active microglia could be a new and promising strategy to inhibit the deterioration of neurodegenerative disease.

Original languageEnglish
Pages (from-to)9-20
Number of pages12
JournalBrain Research
Volume1279
DOIs
Publication statusPublished - 07-07-2009

Fingerprint

Microglia
Lipopolysaccharides
Autophagy
bcl-X Protein
Neurons
Carisoprodol
Microtubules
Neurodegenerative Diseases
Cell Survival
Proteins
Cell Death
Central Nervous System
Adenosine Triphosphate
Apoptosis
Light

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Kaneko, Yoko S. ; Nakashima, Akira ; Mori, Keiji ; Nagatsu, Toshiharu ; Nagatsu, Ikuko ; Ota, Akira. / Lipopolysaccharide extends the lifespan of mouse primary-cultured microglia. In: Brain Research. 2009 ; Vol. 1279. pp. 9-20.
@article{0a168185f0524b52952e766ba3ee9cd0,
title = "Lipopolysaccharide extends the lifespan of mouse primary-cultured microglia",
abstract = "Microglial activation has been implicated in the recognition and phagocytic removal of degenerating neurons; however, this process must be tightly regulated in the central nervous system, because prolonged activation could damage normal neurons. We report that mouse primary-cultured microglia, which are destined to die within a few days under ordinary culture conditions, can live for more than 1 month when kept activated by lipopolysaccharide (LPS) treatment. Primary-cultured microglia treated with sublethal doses of LPS remained viable, without any measurable increase in apoptotic or necrotic cell death. LPS-treated microglia had an arborescent shape, with enlarged somata and thickened cell bodies. Although the amount of intracellular ATP in these microglia was reduced by 2 h after the start of LPS treatment, this had no effect on the viability of the cells. LPS treatment of microglia increased the antiapoptotic factor Bcl-xL protein level at day 1, although the level of the proapoptotic Bcl-associated X-protein was unaffected. Furthermore, the level of microtubule-associated light chain 3, a marker protein for autophagy, decreased at 3 h after exposure to LPS. These data show that the optimal dose of LPS suppresses the induction of both apoptosis and autophagy in primary-cultured microglia, allowing the cells to stay alive for more than 1 month. Because long-lived microglia may play critical roles in the exacerbation of neurodegeneration, our findings suggest that inducing a resting stage in active microglia could be a new and promising strategy to inhibit the deterioration of neurodegenerative disease.",
author = "Kaneko, {Yoko S.} and Akira Nakashima and Keiji Mori and Toshiharu Nagatsu and Ikuko Nagatsu and Akira Ota",
year = "2009",
month = "7",
day = "7",
doi = "10.1016/j.brainres.2009.05.008",
language = "English",
volume = "1279",
pages = "9--20",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

Lipopolysaccharide extends the lifespan of mouse primary-cultured microglia. / Kaneko, Yoko S.; Nakashima, Akira; Mori, Keiji; Nagatsu, Toshiharu; Nagatsu, Ikuko; Ota, Akira.

In: Brain Research, Vol. 1279, 07.07.2009, p. 9-20.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Lipopolysaccharide extends the lifespan of mouse primary-cultured microglia

AU - Kaneko, Yoko S.

AU - Nakashima, Akira

AU - Mori, Keiji

AU - Nagatsu, Toshiharu

AU - Nagatsu, Ikuko

AU - Ota, Akira

PY - 2009/7/7

Y1 - 2009/7/7

N2 - Microglial activation has been implicated in the recognition and phagocytic removal of degenerating neurons; however, this process must be tightly regulated in the central nervous system, because prolonged activation could damage normal neurons. We report that mouse primary-cultured microglia, which are destined to die within a few days under ordinary culture conditions, can live for more than 1 month when kept activated by lipopolysaccharide (LPS) treatment. Primary-cultured microglia treated with sublethal doses of LPS remained viable, without any measurable increase in apoptotic or necrotic cell death. LPS-treated microglia had an arborescent shape, with enlarged somata and thickened cell bodies. Although the amount of intracellular ATP in these microglia was reduced by 2 h after the start of LPS treatment, this had no effect on the viability of the cells. LPS treatment of microglia increased the antiapoptotic factor Bcl-xL protein level at day 1, although the level of the proapoptotic Bcl-associated X-protein was unaffected. Furthermore, the level of microtubule-associated light chain 3, a marker protein for autophagy, decreased at 3 h after exposure to LPS. These data show that the optimal dose of LPS suppresses the induction of both apoptosis and autophagy in primary-cultured microglia, allowing the cells to stay alive for more than 1 month. Because long-lived microglia may play critical roles in the exacerbation of neurodegeneration, our findings suggest that inducing a resting stage in active microglia could be a new and promising strategy to inhibit the deterioration of neurodegenerative disease.

AB - Microglial activation has been implicated in the recognition and phagocytic removal of degenerating neurons; however, this process must be tightly regulated in the central nervous system, because prolonged activation could damage normal neurons. We report that mouse primary-cultured microglia, which are destined to die within a few days under ordinary culture conditions, can live for more than 1 month when kept activated by lipopolysaccharide (LPS) treatment. Primary-cultured microglia treated with sublethal doses of LPS remained viable, without any measurable increase in apoptotic or necrotic cell death. LPS-treated microglia had an arborescent shape, with enlarged somata and thickened cell bodies. Although the amount of intracellular ATP in these microglia was reduced by 2 h after the start of LPS treatment, this had no effect on the viability of the cells. LPS treatment of microglia increased the antiapoptotic factor Bcl-xL protein level at day 1, although the level of the proapoptotic Bcl-associated X-protein was unaffected. Furthermore, the level of microtubule-associated light chain 3, a marker protein for autophagy, decreased at 3 h after exposure to LPS. These data show that the optimal dose of LPS suppresses the induction of both apoptosis and autophagy in primary-cultured microglia, allowing the cells to stay alive for more than 1 month. Because long-lived microglia may play critical roles in the exacerbation of neurodegeneration, our findings suggest that inducing a resting stage in active microglia could be a new and promising strategy to inhibit the deterioration of neurodegenerative disease.

UR - http://www.scopus.com/inward/record.url?scp=67649394108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649394108&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2009.05.008

DO - 10.1016/j.brainres.2009.05.008

M3 - Article

VL - 1279

SP - 9

EP - 20

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -